COLCHICINE REDUCES MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Fadhil, Ameer
Al Wssawi, Abbas
Gumera, Armand
Hashim, Hashim Talib
Al-Shammari, Ali Saad
Abdeltawwab, Mohannad
Amin, Mahmoud
机构：
[1] Univ Warith Al Anbyiaa, Coll Med, Karbala, Iraq
[2] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229-164
引用
下载
收藏
页码：919 / 919
页数：1
相关论文
共 50 条
  • [41] Colchicine for Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials
    Liao, Chunfeng
    Liu, Ping
    Zhou, Yun
    Lu, Di
    Wu, Qi
    HEART SURGERY FORUM, 2021, 24 (05): : E863 - E867
  • [42] Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? An updated meta-analysis of randomized trials
    Elgendy, Islam Y.
    Huo, Tianyao
    Bhatt, Deepak L.
    Bavry, Anthony A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B88 - B89
  • [43] Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials
    Rungapiromnan, W.
    Yiu, Z. Z. N.
    Warren, R. B.
    Griffiths, C. E. M.
    Ashcroft, D. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 890 - 901
  • [44] Improved clinical outcome with eptifibatide in patients undergoing percutaneous coronary intervention: a meta-analysis of four randomized trials
    Patti, G.
    Pasceri, V.
    Nusca, A.
    D'ambrosio, A.
    Di Sciascio, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 329 - 330
  • [45] Head-to-head comparison of prasugrel versus ticagrelor in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Sakurai, Ryota
    Burazor, Ivana
    Bonneau, Heidi N.
    Kaneda, Hideaki
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (05) : 457 - 464
  • [46] Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials
    Pan, Yilong
    Tan, Yuan
    Li, Bin
    Li, Xiaodong
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [47] One-Month Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Controlled Trials
    Mohamed, Mohamed Maali Gumaa
    Shaikh, Safia
    Osman, Mohammed
    Kheiri, Babikir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B73 - B73
  • [48] Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Zhang, Juan
    Yang, Xinchun
    MEDICINE, 2017, 96 (29)
  • [49] ONE-MONTH DURATION OF DUAL ANTIPLATELET THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Mohamed, Mohamed Maali G.
    Shaikh, Safia
    Osman, Mohammed
    Kheiri, Babikir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 674 - 674
  • [50] Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials
    Yilong Pan
    Yuan Tan
    Bin Li
    Xiaodong Li
    Lipids in Health and Disease, 14
12345